[ET Net News Agency, 17 January 2024] KEYMED BIO-B (02162) fell 9.7% to HK$36.9.
It hits an intra-day low of HK$36.75, hitting a 52-week low, and an intra-day high of
HK$40.4. The total shares traded was 3.28 million, with a value of HK$126.2m. The active
buy/sell ratio is 44:56, with net selling turnover of HK$14.61m. BARCLAYS CAPITAL ASIA
accounts for greatest net responsive buying turnover of HK$9.09m, with volume weighted
average price of HK$38.35. CLSA LTD accounts for greatest net responsive selling turnover
of HK$3.05m, with volume weighted average price of HK$37.977. The stock has fallen a
combined 13.2% over the past 2 consecutive trading days.

Basic Information
=================

---------------------------------
Nominal 36.900 % Chg -9.67%
High 40.400 Low 36.750
Shares Tr 3.28m Turnover 126.2m
10-D SMA 41.470 %H.V 47.997
20-D SMA 44.555 VWAP 38.529
50-D SMA 50.376 RSI14 27.709
---------------------------------
Status: Hitting a 52-week low, active buy/sell ratio is 44:56, with net selling turnover
of HK$14.61m, falling a combined 13.2% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
KEYMED BIO-B (02162) 36.90 -9.67
HUTCHMED (00013) 23.95 -6.45
GENSCRIPT BIO (01548) 17.20 -6.01
INNOVENT BIO (01801) 38.70 -4.68
JXR (01951) 2.60 -4.76
EVEREST MED-B (01952) 18.08 -5.34
WUXI BIO (02269) 28.80 -5.42
BEIGENE (06160) 98.90 -3.70
AKESO (09926) 44.05 -6.77
REMEGEN (09995) 24.30 -22.73
---------------------------------------------
(ed)